SOBRsafe Pitch Deck Teardown: A $2.2M SPV for Transdermal

Executive Summary and SPV Structure

Slide 1: Title Slide

The presentation opens by identifying SOBRSafe, LLC as a Special Purpose Vehicle (SPV) created specifically for investment in TransBiotec, Inc. A subtitle notes that TransBiotec is 'soon to be SOBRSafe, Inc.' This indicates a corporate restructuring or a reverse merger scenario common in micro-cap and early-stage industrial tech. The branding features a fingerprint icon within the 'O' of SOBR, signaling the biometric component of the product. The deck is dated First Quarter 2020.

The Problem: Alcohol in Professional Environments

Slide 3: Media Validation

Slide 3 uses a collage of headlines from Fortune, Forbes, CBS, and NBC to establish the urgency of the problem. Headlines mention mandatory breathalyzers in EU cars and incidents involving school bus drivers. This slide serves to prove that the 'Alcohol in the Workplace & Roadways' issue is a current topic of public and regulatory debate, though it does not yet provide specific data points.

Slide 5: Industry Statistics

This slide provides the 'Clear and Present Danger' metrics. It claims that 'Nearly 1/2 of industrial accidents involve alcohol' in manufacturing. For the trucking and fleet sector, it cites '11,000+ Alcohol-related crashes annually.' A central red circle highlights approximately 200,000 injuries and 500 deaths annually. The slide also includes a 'Did You Aware' section (likely a typo for 'Are You Aware') stating that workers with alcohol problems are 270% more likely to have an accident. These figures are used to build the economic and safety case for a preventative solution.

The Solution and Technology

Slide 7: Product Introduction

Slide 7 introduces the SOBRsafe device. The technology is described as 'Transdermal sensor technology' for alcohol detection combined with 'Biometric fingerprint ID' for security. The device is shown in two forms: a mobile unit for fleets and a 'Workplace (WP) Access Control' countertop model. The slide claims a '$16 B estimated size of the preventative market opportunity.' Key value propositions include predictive analytics and the potential for lowering insurance costs. Notably, the slide mentions '2 U.S. patents issued' and ISO 13485 medical compliance for design and manufacturing.

Slide 9: Strategic Plan and Future R&D

The strategic plan focuses on 'Detection Platform Development.' The company is evaluating the use of AI for optical detection of cocaine, marijuana, and opioids. It also mentions a 'Consumer/employee wearable (think FitBit)' for transdermal alcohol detection and a carbon monoxide sensor. This slide suggests that while alcohol is the entry point, the long-term goal is a multi-substance detection platform.

Financial Projections and Business Model

Slide 11: Revenue Model and Use of Proceeds

SOBRsafe outlines a SaaS revenue model based on a 'Low monthly fee per Seat.' The financial table projects a massive scaling: $1.0M in 2021, $7.0M in 2022, $19.0M in 2023, $38.0M in 2024, and $75.0M in 2025. This represents a projected 194% CAGR. The 'Use of Remainder Proceeds' pie chart breaks down the $2.2M raise: $750,000 for General Working Capital, $450,000 for Sales & Marketing, $400,000 for Tech/Product Development, $400,000 for G&A/Public Co. Expenses, and $200,000 for Transaction Expenses.

Slide 13: SPV Offering Summary

This slide details the mechanics of the investment. The maximum offering is $2,200,000. It specifies that $2,000,000 goes toward 'Investment in TransBiotec Convertible Preferred Stock.' The terms include an 8% dividend and an automatic conversion into common stock if the price hits $2.00 for five consecutive days. The slide notes that $1.3 million has already been committed, providing a sense of momentum for potential investors.

Appendix and Market Depth

Slide 15: Appendix Divider

A simple transition slide marking the beginning of supplemental data.

Slide 17: Industry-Specific Use Rates

Slide 17 provides a bar chart of 'Heavy Alcohol Use Rates in Critical Industries.' Construction leads at 17%, followed by Management (10%), Manufacturing (10%), and Transportation & Warehousing (9%). The slide concludes that 'tens of millions of U.S. employees' may be arriving at work under the influence, further justifying the scale of the target market.

Slide 19: Recurring Revenue Rollout

The final slide provides a detailed breakdown of the revenue projections from Slide 11. It lists the market segments contributing to each year's totals. For example, 2021 relies on Fleet and WP Access Control with 6,953 subscriptions. By 2025, the revenue includes contributions from Marijuana & Opioids, Wearables, and Optical detection, totaling 383,033 subscriptions. Pricing assumptions are listed at the bottom, such as a $350 minimum recurring revenue per month per location for centralized devices and $7-$10 per month for various modules.

What Works and What is Missing

What Works

Clear Value Proposition: The shift from invasive breathalyzers to passive transdermal detection is a clear technological advantage for workplace environments. · Specific Market Targeting: By identifying construction and manufacturing as high-risk, the company shows a focused go-to-market strategy. · Structured Investment Terms: The SPV and convertible preferred stock terms are laid out clearly, which is helpful for institutional or sophisticated individual investors.

What is Missing

Team Slide: There is no mention of the founders, management team, or board of directors in these slides. In an SPV/early-stage raise, the 'who' is as important as the 'what.' · Competition: The deck does not address existing competitors in the breathalyzer or drug testing space. · Current Traction: While projections are aggressive, there is no data on current pilots, beta tests, or signed letters of intent (LOIs) from the 'launch verticals.' · Unit Economics: While 'low monthly fee' is mentioned, the actual cost to manufacture the hardware versus the lifetime value (LTV) of a customer is not detailed.

Founder Takeaways

Use Specific Pricing Assumptions: Slide 19 is a great example of how to justify large revenue projections by breaking down the number of subscriptions and the monthly fee per module. · Address the Regulatory Environment: Using media clips (Slide 3) to show that the government is already debating your solution's category helps build a sense of inevitability. · Clarify the Legal Structure: If you are using an SPV or raising for a subsidiary, be as transparent as Slide 13 to avoid confusion during due diligence.